AI for Science

Explore AI for Science through related topics and the articles other pages reference most.

Explore articles

Reset filters
Browse subtopics: Drug Discovery

Articles that also belong to these categories. Counts cover all of AI for Science.

Showing 1-12 of 12 articles

AlphaFold 3

AlphaFold 3 is a biomolecular structure prediction system developed jointly by Google DeepMind and Isomorphic Labs and published in Nature on May 8, 2024.

AI ModelsDrug Discovery

AlphaFold-Multimer

AlphaFold-Multimer is a deep learning system for predicting the three-dimensional structures of protein complexes, released by Google DeepMind in October 2021 as an extension of AlphaFold 2.

Drug DiscoveryGoogle DeepMind

AlphaProteo

AlphaProteo is a machine learning system developed by Google DeepMind for the de novo design of high-affinity protein binders, novel proteins that attach tightly to a chosen target.

AI ModelsDrug Discovery

Boltz

Boltz is a family of open-source biomolecular structure prediction models developed primarily at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Jameel Clinic.

AI ModelsDrug Discovery

Chai-1

Chai-1 is an open multimodal foundation model for biomolecular structure prediction released by the San Francisco startup Chai Discovery on 9 September 2024.

AI ModelsDrug Discovery

Claude for Life Sciences

Claude for Life Sciences is an industry-specific offering from Anthropic that adapts its Claude models for scientific research and drug development, packaging connectors to laboratory and literature platforms…

AnthropicDrug Discovery

OpenFold

OpenFold is an open source, trainable, GPU friendly PyTorch reimplementation of AlphaFold 2, developed initially by the AlQuraishi lab at Columbia University and then governed by the OpenFold Consortium

Drug DiscoveryOpen Source AI

RFdiffusion

RFdiffusion (short for RoseTTAFold diffusion) is a deep-learning system for de novo protein design developed at the University of Washington Institute for Protein Design (IPD) in David Baker's lab.

Diffusion ModelsDrug Discovery

Rentosertib

Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)

Drug DiscoveryHealthcare AI

RoseTTAFold

RoseTTAFold is a deep-learning system for predicting the three-dimensional structures of proteins from amino acid sequence, developed at the Institute for Protein Design (IPD) at the University of Washington…

Drug Discovery